The Claim
Oral melatonin exhibits approximately 15% absolute bioavailability at standard doses due to limited gastrointestinal absorption and extensive first-pass hepatic metabolism, necessitating higher oral dosages to achieve systemic concentrations equivalent to those obtained via parenteral administration.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When you take melatonin pills, your body only absorbs about 15% of it because your gut and liver break it down before it reaches your bloodstream. This is why you need to swallow a much larger pill by mouth to get the same effect as an injection or other non-oral methods.
See the scientific wording
The poor absolute bioavailability of oral melatonin tablets at standard doses (approximately 15%) is associated with either limited gastrointestinal absorption, extensive first-pass hepatic metabolism, or a combination of both physiological processes. This metabolic limitation explains why oral dosing requires higher quantities to achieve systemic concentrations comparable to parenteral administration.
What the research says
1 studyStudy: The Absolute Bioavailability of Oral Melatonin
The authors directly attribute the measured 15% bioavailability to poor gastrointestinal absorption, significant first-pass hepatic metabolism, or both. This mechanistic inference is drawn from the pharmacokinetic data showing substantial drug loss between oral ingestion and systemic circulation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.